CN Patent
CN1199339A — 含有阿帕芬作活性成分的眼用水溶液
Assigned to Santen Pharmaceutical Co Ltd · Expires 1998-11-18 · 27y expired
What this patent protects
本发明涉及含有阿帕芬和添加剂的眼用水溶液,其中通过将离子强度降至0.05或0.05以下使阿帕芬稳定化,还涉及使阿帕芬在该眼用水溶液中稳定化的方法。
USPTO Abstract
本发明涉及含有阿帕芬和添加剂的眼用水溶液,其中通过将离子强度降至0.05或0.05以下使阿帕芬稳定化,还涉及使阿帕芬在该眼用水溶液中稳定化的方法。
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.